Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key COVID-19 Studies Influencing My Practice Following IDWeek 2021—Rapid Recap by Renslow Sherer, MD

September 29 - October 3, 2021; Virtual
Hear unique insights from expert faculty presenting updates and new COVID-19 data from IDWeek 2021, including prevention, treatment of outpatients and hospitalized patients, and long-term outcomes.
Renslow Sherer, MD
Released: October 21, 2021

Information on this Educational Activity

Faculty

Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Renslow Sherer, MD, has disclosed that he has received an unrestricted research grant from Gilead Sciences.

Program Medium

This program has been made available online.

Related Content

From Clinical Care Options (CCO) and Dr. Dalilah Restrepo: guidance on use of the recombinant zoster vaccine (RZV) to prevent shingles complications

person default Dalilah Restrepo, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: November 10, 2021 Expired: November 9, 2022

Download key slides on guidance and CDC recommendations on vaccination to prevent shingles and its complications in the COVID-19 era.

person default Dalilah Restrepo, MD Released: November 10, 2021

Expert commentary on incorporating lessons from the COVID-19 pandemic into improving HCV care among vulnerable populations, from Dr. Gregory Dore and Clinical Care Options (CCO)

Gregory Dore, MBBS, PhD, FRACP, MPH Released: November 8, 2021

Download slides reviewing the latest data and guidance on COVID-19 treatments, including authorized and investigational agents, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Renslow Sherer, MD Released: November 4, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue